Related Experiment Videos

Pulmonary infection with Cryptococcus neoformans in the face of underlying sarcoidosis

Rosemary J Boyton1, Daniel M Altmann, Andrew Wright

  • 1Lung Immunology Group, Department of Biological Sciences/NHLI, Faculty of Medicine, Imperial College London, London, UK. r.boyton@imperial.ac.uk

Respiration; International Review of Thoracic Diseases
|August 18, 2005
PubMed

Insights

A patient with sarcoidosis developed pulmonary cryptococcal infection after pigeon excreta exposure. This case highlights complex immune responses in the lungs and co-existing fungal infections in sarcoidosis patients.

Area of Science:

  • Pulmonology
  • Infectious Diseases
  • Immunology

Background:

  • Cryptococcus neoformans infection pathogenicity is influenced by host immunity and fungal strain virulence.
  • Pulmonary cryptococcosis presentation varies from asymptomatic colonization to severe meningitis.
  • Sarcoidosis involves an excessive Th1-mediated immune response, distinct from immune suppression-associated infections.

Observation:

  • A case of limited pulmonary cryptococcal infection is presented.
  • The patient had a history of sarcoidosis and exposure to pigeon excreta.

Findings:

  • This case demonstrates the intricate immunological responses within the lungs.
  • It underscores the potential for co-existing fungal infections in sarcoidosis patients.

Implications:

  • Clinicians should consider fungal infections like cryptococcosis in sarcoidosis patients.
  • Understanding complex immune interactions is crucial for managing respiratory diseases.
  • Novel immunotherapeutic strategies for cryptococcal infections are being explored.

Related Concept Videos

Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...